Author: Mark Orr

Mark Orr, Ph.D. is an immunologist in the Pre-Clinical Biology group. As a Senior Scientist and Principal Investigator at IDRI his research interests include: • Developing novel adjuvanted vaccines for bacterial diseases including tuberculosis that have a major impact on global health. • The cellular and molecular mechanisms of adjuvant activity. • Immunologic characterization and development of new vaccine adjuvants. Mark is also an Affiliate Assistant Professor in the University of Washington, Department of Global Health Interdisciplinary Pathobiology Program. He has published over 25 peer-reviewed articles in the fields of immunology and vaccine development. He is a member of the American Association of Immunologists and serves on the editorial board of Frontiers in NK Cell Biology. Mark received his Ph.D. from the Department of Immunology at the University of Washington. His thesis work with Dr. Chris Wilson was focused on the immune evasion strategies employed by herpes simplex virus. Mark did his postdoctoral work with Dr. Lewis Lanier at the University of California, San Francisco, where he researched the response of natural killer (NK) cells to viral infection, studying both the signaling pathways and educational programs that shape NK cell responses to infection in vivo.